SMTL ID : 1m6d.1

Crystal structure of human cathepsin F

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.70 Å

Oligo State

homo-dimer

Ligands

2 x MYP: 4-MORPHOLIN-4-YL-PIPERIDINE-1-CARBOXYLIC ACID [1-(3-BENZENESULFONYL-1-PROPYL-ALLYLCARBAMOYL)-2-PHENYLETHYL]-AMIDE(Covalent)

MYP.1: 15 residues within 4Å: Chain A: Q.19, G.23, C.25, W.26, M.64, G.65, G.66, L.67, A.133, Q.140, I.159, D.160, H.161, W.183, M.207 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:L.67, A:A.133, A:I.159, A:W.183 Hydrogen bonds: A:G.66, A:G.66, A:D.160 MYP.2: 15 residues within 4Å: Chain B: Q.19, G.23, C.25, W.26, C.63, M.64, G.65, G.66, L.67, A.133, I.159, D.160, H.161, W.183, M.207 6 PLIP interactions: 6 interactions with chain B Hydrophobic interactions: B:L.67, B:A.133, B:I.159 Hydrogen bonds: B:G.66, B:G.66, B:D.160

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Somoza, J.R. et al., The crystal structure of human cathepsin F and its implications for the development of novel immunomodulators. J.Mol.Biol. (2002)

Release Date

2003-07-15

Peptides

Cathepsin F: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Cathepsin F